LEP and metabolic dysfunction-associated steatohepatitis: A transcriptomic study of NASH also has revealed a concomitant increase of both lepr (leptin receptor) and tgfb1 expression, supporting the connection of leptin pathway and TGFB1 overexpression in NASH [14],